Global Immunofluorescence Assays Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Immunofluorescence Assays Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Immunofluorescence is the specific antigen and antibody reaction where the antibodies are labeled with a fluorescent dye and the antigen-antibody complex is visualized using fluorescent (UV) microscope. Some of the commonly used fluorochromes include Acridine Orange, Lissamine, Rhodamine, and Calcofluor white. Various factors determine the type of immunofluorescence assay used such as time consumed, cost, complexity, flexibility, sensitivity, cross reactivity and many others. It is used in all disciplines of biology including medicine for diagnostics and research. Immunofluorescence assays are used to detect specific proteins in cells that may be in specimen, in culture, in tissues, on microbeads and microarrays, etc.
Immunofluorescence Assays report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Immunofluorescence Assays market is projected to reach US$ 2196.9 million in 2034, increasing from US$ 1678.4 million in 2022, with the CAGR of 3.9% during the period of 2024 to 2034. Demand from Clinical Research and Laboratory Diagnostics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Immunofluorescence Assays industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Immunofluorescence Assays key companies include Thermo Fisher, Inova Diagnostics, Bio-Rad, Abcam, PerkinELmer, Merck Millipore, Cell Signaling Technology, MEDIPAN GMBH and Sino Biological, etc. Thermo Fisher, Inova Diagnostics, Bio-Rad are top 3 players and held % share in total in 2022.
Immunofluorescence Assays can be divided into Antibodies, Kits and Reagents and Labeling Dyes,, etc. Antibodies is the mainstream product in the market, accounting for % share globally in 2022.
Immunofluorescence Assays is widely used in various fields, such as Clinical Research and Laboratory Diagnostics, etc. Clinical Research provides greatest supports to the Immunofluorescence Assays industry development. In 2022, global % share of Immunofluorescence Assays went into Clinical Research filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Immunofluorescence Assays market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Thermo Fisher
Inova Diagnostics
Bio-Rad
Abcam
PerkinELmer
Merck Millipore
Cell Signaling Technology
MEDIPAN GMBH
Sino Biological
Danaher
Vector Laboratories
Segment by Type
Antibodies
Kits and Reagents
Labeling Dyes
Clinical Research
Laboratory Diagnostics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Immunofluorescence Assays market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Immunofluorescence Assays introduction, etc. Immunofluorescence Assays Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Immunofluorescence Assays market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Immunofluorescence Assays report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Immunofluorescence Assays market is projected to reach US$ 2196.9 million in 2034, increasing from US$ 1678.4 million in 2022, with the CAGR of 3.9% during the period of 2024 to 2034. Demand from Clinical Research and Laboratory Diagnostics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Immunofluorescence Assays industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Immunofluorescence Assays key companies include Thermo Fisher, Inova Diagnostics, Bio-Rad, Abcam, PerkinELmer, Merck Millipore, Cell Signaling Technology, MEDIPAN GMBH and Sino Biological, etc. Thermo Fisher, Inova Diagnostics, Bio-Rad are top 3 players and held % share in total in 2022.
Immunofluorescence Assays can be divided into Antibodies, Kits and Reagents and Labeling Dyes,, etc. Antibodies is the mainstream product in the market, accounting for % share globally in 2022.
Immunofluorescence Assays is widely used in various fields, such as Clinical Research and Laboratory Diagnostics, etc. Clinical Research provides greatest supports to the Immunofluorescence Assays industry development. In 2022, global % share of Immunofluorescence Assays went into Clinical Research filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Immunofluorescence Assays market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Thermo Fisher
Inova Diagnostics
Bio-Rad
Abcam
PerkinELmer
Merck Millipore
Cell Signaling Technology
MEDIPAN GMBH
Sino Biological
Danaher
Vector Laboratories
Segment by Type
Antibodies
Kits and Reagents
Labeling Dyes
Segment by Application
Clinical Research
Laboratory Diagnostics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Immunofluorescence Assays market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Immunofluorescence Assays introduction, etc. Immunofluorescence Assays Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Immunofluorescence Assays market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.